What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Xavier Mariette mainly focuses on Internal medicine, Immunology, Rheumatoid arthritis, Surgery and Rheumatology.
All of his Internal medicine and Rheumatism, Infliximab, Adverse effect, Rituximab and Randomized controlled trial investigations are sub-components of the entire Internal medicine study.
His research integrates issues of Physical therapy, Clinical trial, MEDLINE and Cohort in his study of Rheumatism.
His Rheumatoid arthritis research incorporates themes from Prospective cohort study, Risk factor, Abatacept and Arthritis.
His biological study spans a wide range of topics, including Gastroenterology, Incidence and Multiple myeloma.
He focuses mostly in the field of Rheumatology, narrowing it down to topics relating to Confidence interval and, in certain cases, Odds ratio.
His most cited work include:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)
- Genetics of rheumatoid arthritis contributes to biology and drug discovery (1350 citations)
- Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection (666 citations)
What are the main themes of his work throughout his whole career to date?
Xavier Mariette mostly deals with Internal medicine, Immunology, Rheumatoid arthritis, Surgery and Rheumatology.
His study ties his expertise on Gastroenterology together with the subject of Internal medicine.
Immunology is a component of his Antibody, B-cell activating factor, Autoimmune disease, Autoimmunity and Lymphoma studies.
His biological study deals with issues like Physical therapy, which deal with fields such as Clinical trial.
Surgery is closely attributed to Infliximab in his work.
Rheumatology is frequently linked to Rheumatism in his study.
He most often published in these fields:
- Internal medicine (49.52%)
- Immunology (33.33%)
- Rheumatoid arthritis (31.70%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (49.52%)
- Rheumatoid arthritis (31.70%)
- Immunology (33.33%)
In recent papers he was focusing on the following fields of study:
Xavier Mariette focuses on Internal medicine, Rheumatoid arthritis, Immunology, Cohort and Rheumatology.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Gastroenterology, with regards to Salivary gland.
His study looks at the relationship between Rheumatoid arthritis and topics such as Arthritis, which overlap with Adverse effect.
His Cohort research includes themes of Systemic disease, Disease, Clinical research and Epidemiology.
His Rheumatology research includes elements of Rheumatism and Clinical trial.
His study in Rheumatism is interdisciplinary in nature, drawing from both Anti-nuclear antibody and Systematic review, MEDLINE.
Between 2017 and 2021, his most popular works were:
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (197 citations)
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. (182 citations)
- Primary Sjögren’s Syndrome (180 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Xavier Mariette mainly focuses on Internal medicine, Rheumatoid arthritis, Cohort, Adverse effect and Rheumatology.
Xavier Mariette interconnects Gastroenterology and MEDLINE in the investigation of issues within Internal medicine.
He has researched Rheumatoid arthritis in several fields, including Methotrexate, Incidence, Arthritis, Proportional hazards model and Hazard ratio.
His Cohort research incorporates elements of SLICC Criteria, Clinical research, Prospective cohort study and Cohort study.
His Adverse effect study combines topics from a wide range of disciplines, such as Cancer, Immune checkpoint inhibitors, Intensive care medicine, Cancer immunotherapy and Prednisone.
His Rheumatology research integrates issues from Clinical trial and Discontinuation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
